Minimally invasive surgery for the treatment of hyperparathyroidism

Israel Medical Association Journal

Volumn 7, Issue 5, 2005, Pages 323-327

  Mekel, Michal ^a,b   Mahajna, Ahmed ^a,b   Ish Shalom, Sofia ^a,b   Barak, Michal ^a,b   Segal, Elena ^a,b   Salih, Adel Abu ^a,b   Bishara, Bishara ^a,b   Shen Or, Zila ^a,b   Krausz, Michael M ^a,b  

^a RAMBAM MEDICAL CENTER   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Minimal invasive surgery; Neck exploration; Parathyroid hormone; Parathyroidectomy; Sestamibi scan

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; PARATHYROID HORMONE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DISEASE CLASSIFICATION; ECHOGRAPHY; FEMALE; HUMAN; HYPERPARATHYROIDISM; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MINIMALLY INVASIVE SURGERY; OPERATION DURATION; PARATHYROID ADENOMA; PARATHYROID CARCINOMA; PARATHYROIDECTOMY; PREOPERATIVE EVALUATION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SURGICAL TECHNIQUE; TUMOR LOCALIZATION;

ADENOMA; ADULT; AGED; AGED, 80 AND OVER; CALCIUM; CARCINOMA; FEMALE; HUMANS; HYPERPARATHYROIDISM; HYPERPLASIA; MALE; MIDDLE AGED; MONITORING, INTRAOPERATIVE; PARATHYROID GLANDS; PARATHYROID HORMONE; PARATHYROID NEOPLASMS; PARATHYROIDECTOMY; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SURGICAL PROCEDURES, MINIMALLY INVASIVE; TECHNETIUM TC 99M SESTAMIBI; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 18744389773     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Mandel F. Kliniches und experimentalles zuer frage der lokalisierten und generalisierten ostitis fibrosa. Arch Klin Chir 1926;143:245-84.
2. Irvine GL III, Sfakianakis G, Yeung I, et al. Ambulatory parathyroidectomy for primary hyperparathyroidism. Arch Surg 1996;31:1074-8.
3. Chen H, Sokol LJ, Udelsman R. Outpatient minimally invasive parathyroidectomy: a combination of sestamibi-SPECT localization, cervical block anesthesia, and intraoperative parathyroid hormone assay. Surgery 1999;126:1016-22.
4. Undelsman R, Donovan PI, Sokoll LJ. One-hundred consecutive minimally invasive parathyroid explorations. Ann Surg 2000;232:331-9.
5. Denham DW, Norman I. Cost-effectiveness of preoperative sestamibi scan for primary hyperparathyroidism is dependent solely upon the surgeon's choice of operative procedure. J Am Coll Surg 1998:186:293-305.
6. Civelek AC, Ozalp E, Donovan P, Udelsman R. Prospective evaluation of delayed Technetium-99m sestamibi SPECT scintigraphy for preoperative localization of primary hyperparathyroidism. Surgery 2002; 131:149-57.
7. Undelsman R. Six hundred fifty-six consecutive explorations for primary hyperparathyroidism. Ann Surg 2002;235:665-72.
8. Vogel LM, Lucas R, Czako P. Unilateral parathyroid exploration. Am Surg 1998;64:693-6.
9. Prager G, Czerny C, Ofluoglu S, et al. Impact of localization studies on the feasibility of minimally invasive parathyroidectomy in an endemic goiter region. J Am Coll Surg 2003;196:541-8.
10. Bilezikan JP, Potts JT, Jr, Fuleihan Gel-H, et al. Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century. J Bone Miner Res 2002;17:(Suppl 2)N2-11
11. Bilezikian JP, Silverberg SJ. Asymptomatic primary hyperparathyroidism N Engl J Med 2004;350:1746-51.
12. Clark OH. Current management of patients with hyperparathyroidism. Adv Surg 1996;30:179-87.
13. Bilezikian JP. Primary hyperparathyroidism: when to observe and when to operate. Endocrinol Metab Clin North Am 2000; 29:465-78.
14. Irwin GL, Carneiro DM, Solorzano CC. Progress in operative management of sporadic primary hyperparathyroidism over 34 years. Ann Surg 2004;239:704-11.
15. Heller KS, Attie JN, Dubner S. Parathyroid localization: inability to predict multiple gland involvement. Am J Surg 1993;166:357-9.
16. Zmora O, Schachter PP, Heyman Z, et al. Correct preoperative localization: does it permit a change in operative strategy for primary hyperparathyroidism? Surgery 1995;118:932-5.
17. Feingold DL, Alexander HR, Chen CC, et al. Ultrasound and sestamibi scan as the only preoperative imaging tests in reoperation for parathyroid adenomas. Surgery 2000;128:1103-9.
18. Dillavou ED, Jenoff JS, Intenso CM, Cohn HE. The utility of sestamibi scanning in the operative management of patients with primary hyperparathyroidism. J Am Coll Surg 2000;190:540-5.
19. Krausz Y, Lebensart PD, Klein M, et al. Preoperative localization of parathyroid adenoma in patients with concomitant thyroid nodular disease. World J Surg 2000;24:1573-8.
20. Nichol PF, Starling JR, Mack E, et al. Long-term follow-up of patients with tertiary hyperparathyroidism treated by resection of a single or double adenoma. Ann Surg 2002;235:673-80.
21. Garvin PJ, Castaneda M, Linderer R, Dickhans M. Management of hypercalcemic hyperparathyroidism after renal transplantation. Arch Surg 1985;120:578-83
22. Gasparri G, Camandona M, Abona GC, et al. Secondary and tertiary hyperparathyroidism: causes of recurrent disease after 446 parathyroidectomies. Ann Surg 2001;233:65-9.
23. Kilgo MS, Pirsch JD, Warner TF, Starling JR. Tertiary hyperparathyroidism after renal transplantation: surgical strategy. Surgery 1998;124:677-83.